Pegah Farrokhi, Alireza Sadeghi, Mehran Sharifi, Rachel Riechelmann, Azadeh Moghaddas
BACKGROUND AND PURPOSE: This study aimed to compare the efficacy and toxicity of perioperative chemotherapy regimens including epirubicin, cisplatin, 5-fluorouracil (ECF), docetaxel, cisplatin, 5-fluorouracil (DCF), leucovorin, 5-fluorouracil, oxaliplatin (FOLFOX), and 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) to identify the most effective chemotherapy regimen with less toxicity. EXPERIMENTAL APPROACH: This retrospective cohort study (2014-2021) was based on 152 eligible resectable gastric cancer patients who had received one of the perioperative mentioned chemotherapy regimens and followed for at least two years...
December 2022: Research in Pharmaceutical Sciences